3
Participants
Start Date
December 31, 2006
Primary Completion Date
May 31, 2013
Study Completion Date
May 31, 2013
Imatinib Mesylate (IM)
IM Therapy of (100 mg or 400 mg) tablets by mouth, same dose each day.
TALL-104 cells
TALL-104 cells will be given intravenously over 1 hour at the dose of 109 cells daily for 4 days, on days 1 to 4 of the cycle, and then again on days 7, 10, 14, 17 and 21 of the cycle. One cycle is equal to 28 days. Patients will receive only one cycle of therapy with TALL-104 cells
UT MD Anderson Cancer Center, Houston
Collaborators (1)
Abiogen Pharma
INDUSTRY
M.D. Anderson Cancer Center
OTHER